Cargando…
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana’s Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality
BACKGROUND: In 2012, as a pilot for Botswana’s national Xpert MTB/RIF (Xpert) rollout plans, intensified tuberculosis (TB) case finding (ICF) activities were strengthened at 22 HIV treatment clinics prior to phased activation of 13 Xpert instruments. Together, the strengthened ICF intervention and X...
Autores principales: | Auld, Andrew F., Agizew, Tefera, Pals, Sherri, Finlay, Alyssa, Ndwapi, Ndwapi, Boyd, Rosanna, Alexander, Heather, Mathoma, Anikie, Basotli, Joyce, Gwebe-Nyirenda, Sambayawo, Shepherd, James, Ellerbrock, Tedd V., Date, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080709/ https://www.ncbi.nlm.nih.gov/pubmed/27782821 http://dx.doi.org/10.1186/s12879-016-1905-4 |
Ejemplares similares
-
Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana
por: Agizew, Tefera, et al.
Publicado: (2017) -
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
por: Agizew, Tefera, et al.
Publicado: (2017) -
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
por: Agizew, Tefera, et al.
Publicado: (2019) -
The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear
por: Zimba, Onani, et al.
Publicado: (2019) -
Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria
por: Agizew, Tefera, et al.
Publicado: (2020)